Forum Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,152
Closed -$925K 421
2025
Q4
$925K Sell
17,152
-5,060
-23% -$243K 0.01% 265
2025
Q3
$1M Buy
22,212
+7,649
+53% +$357K 0.01% 235
2025
Q2
$674K Sell
14,563
-4,166
-22% -$205K 0.01% 311
2025
Q1
$1.14M Buy
18,729
+1,845
+11% +$108K 0.02% 180
2024
Q4
$955K Buy
16,884
+5,462
+48% +$305K 0.02% 215
2024
Q3
$591K Buy
11,422
+1,447
+15% +$67.9K 0.01% 283
2024
Q2
$414K Buy
9,975
+330
+3% +$14.8K 0.01% 366
2024
Q1
$523K Buy
9,645
+9
+0.1% +$458 0.01% 310
2023
Q4
$494K Sell
9,636
-13,174
-58% -$692K 0.01% 292
2023
Q3
$1.32M Sell
22,810
-58
-0.3% -$3.55K 0.03% 127
2023
Q2
$1.46M Buy
22,868
+2,234
+11% +$150K 0.03% 114
2023
Q1
$1.43M Sell
20,634
-791
-4% -$55.8K 0.04% 106
2022
Q4
$1.54M Buy
21,425
+513
+2% +$38.7K 0.05% 88
2022
Q3
$1.49M Sell
20,912
-1,876
-8% -$136K 0.07% 80
2022
Q2
$1.75M Buy
22,788
+3,200
+16% +$244K 0.09% 71
2022
Q1
$1.43M Buy
19,588
+1,380
+8% +$92.7K 0.07% 87
2021
Q4
$1.14M Buy
+18,208
New +$1.07M 0.06% 112

Other funds holding BMY

Forum Financial Management's BMY Position: Q1 2026 in Review

Forum Financial Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 17,152 shares — an estimated $925K sold.

Forum Financial Management first reported a position in BMY in Q4 2021 and held it in 17 quarters. The position peaked at $1.75M in Q2 2022. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Forum Financial Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 17,152 Bristol-Myers Squibb shares in Q1 2026, an estimated $925K.
  • Forum Financial Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 17 quarters.
  • Forum Financial Management's Bristol-Myers Squibb position peaked at $1.75M in Q2 2022.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.